Samir Mehta Breaks Into the Top 10: The Power of a Well-Timed Merger

Torrent Pharma's chairman grew his family's wealth 52% to ₹1.89 lakh crore after completing the JB Chemicals deal.

Samir Mehta Breaks Into the Top 10: The Power of a Well-Timed Merger

Samir Mehta and family enter the top 10 of the M3M Hurun India Rich List 2026, ranking tenth with ₹1,89,400 crore. That is up 52% from last year.

According to coverage of the list, the jump followed the completion of Torrent Pharmaceuticals' merger with JB Chemicals.

An Ahmedabad pharma story

Mehta chairs Torrent Pharmaceuticals, part of the Ahmedabad-based Torrent Group. Like Dilip Shanghvi and Cyrus Poonawalla, he is one of three pharma and healthcare leaders in this year's top 10.

Pharma wealth rose 25% across the list, reflecting a strong year for the sector.

Why M&A changes trajectories

A well-chosen acquisition can add products, markets and scale far faster than organic growth. When investors believe in the combined business, the value can show up quickly in valuations.

The communication around a deal matters too. Clear messaging on why two companies fit together helps employees, customers and investors back the plan.

Lessons for founders and leaders

  • Buy for strategic fit, not size alone. The best deals fill clear gaps.
  • Execute the integration. Value comes from making the combined company work.
  • Explain the 'why' early and often. Confidence in the story drives confidence in the numbers.

Mehta's entry to the top 10 shows how one well-executed deal can change a company's place in India's business landscape.

Kayvue helps founders and business leaders build credibility through earned media in India's leading business publications.

Written by

  • Hurun India Rich List
  • Samir Mehta
  • Torrent Pharma
  • Mergers and Acquisitions
  • Pharmaceuticals

Want your story in Forbes India?

I’m ready for PR

More from the blog